36E79725D0037
Indefinite Delivery Contract
Overview
Government Description
NEW AWARD FOR LOSARTAN TABLETS WITH XLCARE PHARMACEUTICALS, INC. PERIOD OF PERFORMANCE IS 9/24/2025-9/23/2026.
Awardee
Awarding / Funding Agency
Pricing
Fixed Price
Set Aside
None
Extent Competed
Full And Open Competition
Multiple / Single Award
Single Award
Who Can Use
Multiple Agencies
Vehicle Ceiling
$37,933,102 (0% Used)
Related Opportunity
Xlcare Pharmaceuticals was awarded
Indefinite Delivery Contract 36E79725D0037 (36E797-25-D-0037)
by
National Acquisition Center
for New Award For Losartan Tablets With Xlcare Pharmaceuticals, Inc. Period Of Performance Is 9/24/2025-9/23/2026.
in September 2025.
The IDC
was awarded
through solicitation Losartan Tablets
full & open
with
NAICS 325412 and
PSC 6505
via direct negotiation acquisition procedures with 8 bids received.
The total ceiling is $37,933,102, of which 0% has been used.
Status
(Open)
Modified 7/2/25
Period of Performance
9/23/25
Start Date
9/23/26
Ordering Period End Date
Task Order Obligations
$0
Total Obligated
$0
Current Award
$0
Potential Award
Opportunity Lifecycle
Procurement history for 36E79725D0037
Transaction History
Modifications to 36E79725D0037
People
Suggested agency contacts for 36E79725D0037
Competition
Number of Bidders
8
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Awardee UEI
MEAUS5WHBJJ7
Awardee CAGE
86SL9
Agency Detail
Awarding Office
36E797 NAC PHARMACEUTICALS (36E797)
Funding Office
36E797 NAC PHARMACEUTICALS (36E797)
Created By
michael.olszewski@va.gov
Last Modified By
diana.eaton@va.gov
Approved By
diana.eaton@va.gov
Legislative
Legislative Mandates
None Applicable
Awardee District
GA-13
Senators
Jon Ossoff
Raphael Warnock
Raphael Warnock
Representative
David Scott
Last Modified: 7/2/25